Ben Lamm
Overview
Ben Lamm is co-founder and CEO of Colossal Biosciences. Earlier ventures include Chaotic Moon, Team Chaos, Conversable and Hypergiant. His career expanded from software and digital experiences into AI and conservation biotechnology, with a business leadership role at Colossal.[1]
Contents25 sections
Key facts
2004Baylor and Simply Interactive
Lamm earned a BBA from Baylor University in 2004. While studying, he developed a class project into Simply Interactive, offering interactive marketing and e-learning services. A university alumni profile reported a six-figure contract with its first client.[2]
2010Founding Chaotic Moon
In 2010, Lamm co-founded Austin-based Chaotic Moon and served as CEO. The studio worked on digital-product design, prototypes and user experiences, combining software development with experimental products.[3]
July 2015Accenture acquires Chaotic Moon
On July 22, 2015, Accenture announced its acquisition of Chaotic Moon to expand digital design and innovation capabilities. The announcement identified Lamm as co-founder and CEO; financial terms were not disclosed.[3]
2016Team Chaos and games
Lamm and Andrew Busey co-founded game company Team Chaos. Baylor’s alumni publication records its acquisition by Zynga in 2016.[4]
2018Founding Hypergiant
Lamm founded Hypergiant in 2018, extending his work in artificial intelligence. The company later focused on decision-support and situational-awareness software for defense, space and critical infrastructure.[5]
October 2018LivePerson acquires Conversable
On October 1, 2018, LivePerson announced its acquisition of Conversable, co-founded by Lamm and Andrew Busey. Lamm was CEO. Conversable helped businesses automate conversations across messaging and voice channels, and its team joined LivePerson.[6]
2019Meeting George Church
According to the Wyss Institute’s project account, Lamm visited George Church’s laboratory in 2019. Their contact led toward the collaboration behind Colossal, combining Church’s genomics research with Lamm’s experience building companies.[7]
September 2021Launching Colossal
On September 13, 2021, Colossal launched with $15 million in seed funding, Lamm as CEO and Church among its co-founders. It established sponsored-research and licensing arrangements with Harvard. An initial objective was a cold-adapted animal with mammoth traits developed through Asian-elephant research, a research goal rather than an accomplished mammoth revival.[8]
September 2022Spinning out Form Bio
On September 27, 2022, Colossal announced the spinout of Form Bio and its $30 million Series A. Lamm was a co-founder, while Andrew Busey and Kent Wakeford were co-CEOs. The business commercialized tools for computational-biology data processing, analysis and workflows.[9]
August 2023Trive Capital acquires Hypergiant
An August 22, 2023 announcement disclosed Trive Capital’s acquisition of Hypergiant to support its AI software business. Mike Betzer was the company’s CEO at that point; Lamm commented as its founder.[5]
2024Co-founding Breaking
March 2025The woolly-mouse experiment
On March 4, 2025, Colossal announced woolly mice produced through eight edits involving seven genes, altering coat-related traits. It presented the work as a model for multiplex editing and mammoth-associated characteristics. The animals remained mice; the experiment did not establish mammoth revival.[12]
April 2025The dire-wolf announcement
On April 7, 2025, Colossal announced three pups named Romulus, Remus and Khaleesi, calling them revived dire wolves. Its account described 20 edits across 14 genes in gray-wolf cells, followed by cloning and domestic-dog surrogacy. Specialist criticism challenged the species designation and conservation implications.[13][14]
April 2025Canid specialists’ objections
On April 18, 2025, the IUCN SSC Canid Specialist Group characterized the animals as genetically modified gray wolves, not dire wolves or established conservation proxies. It acknowledged potential technical uses but argued that appearance alone did not demonstrate ecological function or conservation benefit, emphasizing living species and their habitats.[14]
September 2025Expanded funding and dodo research
In September 2025, Colossal announced $120 million in additional funding, bringing the round to $320 million and cumulative funding above $555 million, at a disclosed $10.32 billion valuation. Dodo-project updates included pigeon primordial-germ-cell culture and potential surrogate chickens. These were experimental-platform advances, not the birth of living dodos.[15]
November 2025Acquiring Viagen
In November 2025, Colossal announced its acquisition of Viagen Pets and Equine, a provider of animal genetic preservation and cloning services. Viagen became a wholly owned subsidiary with its existing leadership, supporting Colossal’s intended expansion in endangered-species cloning.[16]
June 2026A conservation framework with the U.S. Interior Department
On June 25, 2026, the U.S. Department of the Interior announced a collaboration framework with Colossal involving the Fish and Wildlife Service, biobanking and conservation genomics. The memorandum did not itself obligate federal funds; specific projects required separate arrangements.[17]
September 2026Appearing at Moonshots Live
Lamm joined a Moonshots Live discussion recorded on September 25, 2026 and published on September 30. The official episode page and video description list AI, biology, gene editing and species conservation among its subjects, alongside Peter Diamandis, Salim Ismail, Dave Blundin and Alex Wissner-Gross.[18][19]
Astromech and biological AI
Astromech names Lamm and George Church among its founding members. It proposes a Large Life Model integrating biological data across species to investigate genotype–phenotype relationships. The website describes a development program, rather than demonstrated general predictive mastery of biology.[20]
Colossal’s response to the controversy
In its document addressing IUCN guidance, Colossal describes dire-wolf proxies and acknowledges genetic, phenotypic and possible behavioral differences from the extinct species. It states there is no current plan for wild release and argues that the work can support genetic rescue and reproductive technology for living canids. This is the company’s assessment, not IUCN endorsement.[21]
Conservation and nonprofit activity
The Colossal Foundation is Colossal’s nonprofit arm, applying genetic engineering, biobanking and AI monitoring to wildlife conservation. Linked to the company’s technology development, its work emphasizes collaboration with conservationists and local communities to move research into field projects.[22]
Public organizational roles
Public accounts
The official MoonshotsMoonshotsMoonshots, formally Moonshots with Peter Diamandis, is a technology podcast founded by Peter Diamandis. It discusses artificial intelligence, entrepreneurship and technological change, and launched its Moonshots LIVE gathering in Los Angeles in 2026.Open the full entry video description links Lamm’s X account, @BenLamm, and LinkedInLinkedInLinkedIn is a social networking platform for professionals. It was founded in 2002 by Reid Hoffman and others, launched in 2003, and listed on the New York Stock Exchange in 2011; after Microsoft acquired it for approximately $26.2 billion in 2016, it became a wholly owned Microsoft subsidiary. Its revenue comes from membership subscriptions, advertising, and recruitment solutions.Open the full entry profile, benlamm. Colossal’s website provides his company role and team biography.[18][1]
Sources
- Company — Ben Lamm (opens in a new window)
- Ben Lamm, BBA 2004 (opens in a new window)
- Accenture Acquires Chaotic Moon to Continue Growing Its Digital Design and Innovation Capabilities (opens in a new window)
- Alumni News — Spring 2019 (opens in a new window)
- Hypergiant Industries Partners with Trive Capital (opens in a new window)
- LivePerson acquires Conversable (opens in a new window)
- Biotechnology for conservation and de-extinction (opens in a new window)
- Colossal Biosciences Launches with $15M Seed Funding (opens in a new window)
- Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences (opens in a new window)
- Startups and Licensing — Breaking (opens in a new window)
- Breaking — founders and technology (opens in a new window)
- Colossal Creates the Colossal Woolly Mouse (opens in a new window)
- Colossal Dire Wolves: Brought Back from 12,000-Year Extinction Through Revolutionary Gene Editing (opens in a new window)
- Conservation perspectives on gene-editing in wild canids (opens in a new window)
- Colossal Advances Dodo De-Extinction and Secures an Additional $120M in Funding (opens in a new window)
- Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning (opens in a new window)
- Interior and Colossal Biosciences Announce Conservation Collaboration (opens in a new window)
- Anthropic’s Wet Lab, Artificial Wombs in 24 Months, and Scalable Gene Editing | MOONSHOTS Live #297 (opens in a new window)
- Why We’re Living in a Biological Singularity (opens in a new window)
- Astromech — Large Life Model (opens in a new window)
- Alignment of Colossal’s Dire Wolf De-Extinction Project with IUCN SSC Guiding Principles (opens in a new window)
- About Us — Colossal Foundation (opens in a new window)
- Advisory Council — Ben Lamm (opens in a new window)
- Club Officials — Board of Trustees (opens in a new window)
- Board of Directors — Ben Lamm (opens in a new window)